Physician profile
Joseph E Roberts
NPI 1518955269
$953.15
in general payments reported to CMS, 2019-2025
13 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $28.10 · 2021: $143 · 2022: $86.94 · 2023: $41.18 · 2024: $184 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $484.94 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $113.64 | 2019 | |
| Abbott Laboratories | $63.95 | 2024 | Eterna |
| Averitas Pharma INC. | $25.50 | 2025 | Qutenza |
| Eisai INC. | $25.21 | 2021-2022 | |
| Melinta Therapeutics, LLC | $24.61 | 2023 | Rezzayo, Vabomere, Kimyrsa |
| Beta Bionics, INC. | $17.96 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Solventum Corporation | $16.43 | 2024 | Activ.A.C. |
| Glaxosmithkline, LLC. | $16.41 | 2020 | |
| Lilly USA, LLC | $14.31 | 2025 | Zepbound |
| Abbvie INC. | $13.50 | 2021 | |
| Pfizer INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.